Names and Identifiers

• • cefotetan
  • Cefotetan acid
  • Cefotetan disodium
  • Apacef
  • Apatef
  • CEFOTETAN SODIUM
  • Ceftenon
  • Cepan Darvilen
  • Yamatetan
  • (6R,7S)-7-[[4-(1-Amino-3-hydroxy-1,3-dioxopropan-2-ylidene)1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic a
  • (6R,7S)-7-[[4-(1-Amino-3-hydroxy-1,3-dioxopropan-2-ylidene)1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Cefotetanum
  • ICI 156834
  • MLS002153829
  • Cefotetanum [INN-Latin]
  • (6R,7S)-7-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • SMR001233197
  • 7beta-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-dideh
  • NCGC00179507-01
  • BPBio1_000668
  • disodium 7-[[4-(2-amino-1-carboxylato-2-oxo-ethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
  • BRN 1208088
  • (6R,7S)-7-[[4-(2-amino-1-carboxy-2-keto-ethylidene)-1,3-dithietane-2-carbonyl]amino]-8-keto-7-methoxy-3-[[(1-methyltetrazol-5-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • CEFOTETAN [USAN]
  • HMS2234C15
  • CS-0092723
  • Cefotetan, Antibiotic for Culture Media Use Only
  • C17H17N7O8S4
  • DB01330
  • W-104601
  • NCGC00016914-06
  • CEFOTETAN [USP IMPURITY]
  • DTXSID1022762
  • AS-56133
  • SCHEMBL61376
  • AKOS015896100
  • (6R,7S)-7-(4-(Carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
  • D00260
  • SPBio_002545
  • ICI 156,834
  • NSC 760045
  • SR-01000842155
  • (6R,7S)-4-((2-CARBOXY-7-METHOXY-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-7-YL)CARBAMOYL)-1,3-DITHIETANE-.DELTA.(SUP 2,.ALPHA.)-MALONAMIC ACID
  • ICI-156834
  • (6R,7S)-7-[[[4-(2-Amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
  • UNII-48SPP0PA9Q
  • (6R,7S)-4-((2-Carboxy-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-7-yl)carbamoyl)-1,3-dithietane-delta(sup 2,alpha)-malonamic acid
  • BDBM80643
  • Prestwick2_000473
  • cid_53025
  • YM 09330
  • ICI156834
  • C2936
  • DTXCID202762
  • CEFOTETAN [MI]
  • Cefotetan [USAN:USP:INN:BAN]
  • Ici-156,834
  • CEFOTETAN [VANDF]
  • Tox21_110681
  • CHEBI:3499
  • 48SPP0PA9Q
  • CEFOTETAN [JAN]
  • EINECS 274-093-3
  • HMS1569O08
  • Cefotetan (JP17/USP/INN)
  • (6R,7S)-7-{4-[carbamoyl(carboxy)methylidene]-1,3-dithietane-2-amido}-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • CCG-220473
  • GTPL10936
  • (6R,7S)-7-(4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • A836615
  • NS00011561
  • BSPBio_000606
  • Q2602246
  • 7beta-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
  • EN300-19766312
  • (6R,7S)-7-[[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]-oxomethyl]amino]-7-methoxy-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • HY-N6670
  • (6R,7S)-7-[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Prestwick0_000473
  • SR-01000842155-3
  • NCGC00016914-01
  • (6R,7S)-7-(4-(carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5- yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid
  • 69712-56-7
  • CEFOTETAN [MART.]
  • C06886
  • CEFOTETAN [INN]
  • BCP10745
  • Prestwick1_000473
  • 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha))-
  • AMY28799
  • HMS3713O08
  • NSC-760045
  • CAS-69712-56-7
  • Prestwick3_000473
  • CEFOTETAN [WHO-DD]
  • HMS2096O08
  • (6R,7S)-7-[[4-[1-azanyl-3-oxidanyl-1,3-bis(oxidanylidene)propan-2-ylidene]-1,3-dithietan-2-yl]carbonylamino]-7-methoxy-3-[(1-methyl-1,2,3,4-tetrazol-5-yl)sulfanylmethyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • CEFOTETAN [USP MONOGRAPH]
  • AB00513847
  • CHEMBL474579
  • AC-2141
  • Cefotetan (JP18/USP/INN)
  • SRZNHPXWXCNNDU-RHBCBLIFSA-N
  • Cefotetan
  • +expand
• • MDL： MFCD00864983
  • Inchi： 1S/C17H17N7O8S4/c1-23-16(20-21-22-23)34-4-5-3-33-15-17(32-2,14(31)24(15)7(5)11(29)30)19-9(26)13-35-12(36-13)6(8(18)25)10(27)28/h13,15H,3-4H2,1-2H3,(H2,18,25)(H,19,26)(H,27,28)(H,29,30)/b12-6-/t13?,15-,17+/m1/s1
  • InChI Key： SRZNHPXWXCNNDU-IXOPCIAXSA-N
  • SMILES： S1CC(CSC2=NN=NN2C)=C(C(=O)O)N2C([C@]([C@@H]12)(NC(C1S/C(=C(/C(=O)O)\C(N)=O)/S1)=O)OC)=O

Computed Properties

Experimental Properties